Introduction {#sec1-1}
============

Herbal medicine is known as botanical medicine which refers to use of plants for medicinal purposes.^[@ref1]^ Herbal medicines include herbs, herbal materials, herbal preparations and finished herbal products that contain parts of plants or other plant materials as active ingredients. It is still the mainstay of about 75-80% of the world population, mainly in the developing countries, for primary health care because of better cultural acceptability, better compatibility with the human body and lesser side effects.^[@ref2]^

The World Health Organization (WHO) has recently defined traditional medicine (including herbal drugs) as comprising therapeutic practices that have been in existence, often for hundreds of years, before the development and spread of modern medicine and are still in use today.^[@ref3]^ Traditional medicine is the synthesis of therapeutic experience of generations of practicing physicians of indigenous systems of medicine. The traditional preparations comprise medicinal plants, minerals, organic matter, *etc*. Herbal drugs constitute only those traditional medicines, which primarily use medicinal plant preparations for therapy.^[@ref2]^

Herbal medicines have gained popularity as a natural approach for treatment of varying conditions or illness. It is a form of alternative medicine that includes use of different plant and plant extracts for treatment of diseases. Man has practiced their use for treatment of diseases for many years and it has become widely used as alternative medicines.^[@ref4]^ In Nigeria today, herbal remedies are selling even more than the synthetic drugs. Consumers prefer these formulas due to easy accessibility (less expensive), and claims that they have fewer side effects since they are natural products. Herbal medicinal products are unlikely to pose a significant threat to human health; nonetheless, it is important to validate their safety. The confidence in herbal medicines is backed by their long-term usage. Validation of their safety is necessary because crude herbal medicines are given in most cases without accurate dosage and over ingestion can result in toxicity.^[@ref5]^ It is also possible for the plant to have silent toxic effect that may not be evident within a short time.^[@ref6]^ The use of herbal medicinal products may present potential risk to human health,^[@ref7]^ but some toxic herbal medicines have been proven to have beneficial effects at very low doses.^[@ref6]^ To protect public health, it is necessary to ensure that all medicines, including unlicensed products, are safe for human consumption and of suitable quality. Herbal medicines are required to meet the same safety, quality and efficacy criteria as any other licensed medicine. Serious liver toxicity has been reported to be associated with the use of some herbal medicines.^[@ref5]^ Recent research revealed that adverse reactions to herbal products are under-reported.^[@ref8]^ The more subtle and chronic forms of toxicity, such as carcinogenicity, mutagenicity, and hepatotoxicity, may well have been overlooked by previous generations and it is these types of toxicity that are of most concern when assessing the safety of herbal remedies.^[@ref9]^

The root of *Mondia whitei* is traditionally used in the treatment of urinary tract infection, headache, jaundice while the whole plant is used to treat diarrhea.^[@ref10],[@ref11]^ The aqueous extracts and root have also been reported to be an efficacious aphrodisiac for the treatment of male impotence.^[@ref12]^ *Khaya senegalensis* on the other hand has been reported to exhibit anti-inflammatory effects;^[@ref13]^ treatment of jaundice, dermatose, diarrhea and venereal diseases and hookworm infection.^[@ref14],[@ref15]^ The seed and juice of pounded leaves of *Capparis erythrocarpus* are used against child convulsive fever and the pounded root is used in severe abscess while in Tanzania and India, the pounded root is used for the treatment of inflammation of the connective tissue of the eye.^[@ref16],[@ref17]^ *Xylopia aethiopica* is commonly administered after child birth to arrest bleeding owing to his antiseptic properties.^[@ref18]^ It has also been reported to be an antioxidant;^[@ref19]^ anti-hypertensive and diuretic effects^[@ref20]^ and hepatoprotective.^[@ref21]^ Limited toxicological data are available on medicinal plants. Class bitters^®^ (CB) is a polyherbal formula produced by Classic Herbal Centre in Accra, Ghana. Ethnomedicinally, CB is taken three times daily for the treatment of diabetes mellitus, muscle pains, joint pains, backache, general body pains and sexual weakness.^[@ref22]^ This present study was carried out to investigate the toxicity effect of CB - a polyherbal formula on serum electrolytes and hematological indices of male Wistar albino rats.

Materials and Methods {#sec1-2}
=====================

Herbal sample {#sec2-1}
-------------

Five bottles of CB with the same batch number Bx/04/10 produced by Classic Herbal Centre, Accra, Ghana, where use in these study. They were purchased from a local herbal drug retailer in Rumuola, Port Harcourt, Rivers State, Nigeria.

Experimental animals {#sec2-2}
--------------------

A total of 30 male Wistar albino rats weighing between 140 to 160 g used in this study were obtained from the Animal House of the Department of Biochemistry, University of Port Harcourt, Choba, Rivers State, Nigeria. The animals were kept singly in a cross-ventilated house and were fed with standard rat pellet and water *ad libitum*. The rats were acclimatized for 7 days. The experiment was performed after the experimental protocol was approved by the Institutional Animal Ethics Committee.

Acute toxicity test {#sec2-3}
-------------------

Healthy male Wistar albino rats weighing between 140-160 g maintained under standard laboratory conditions were used for acute toxicity test according to the Organization for Economic Cooperation and Development (OECD) guidelines 425 (OECD 2000 guidelines). A total of ten animals were used which received a single oral-dose of 2000 mg/kg body weight (b.w.) of CB. Animals were kept overnight fasting prior to drug administration by oral gavage. After administration of drug sample, food was withheld for further 3-4 h. animals were observed individually at least once during first 30 min after dosing, periodically during first 24 h (with special attention during the first 4 h) and daily thereafter for a period of 14 days. Daily observation on the changes of skin and fur, eyes and mucus membrane (nasal), respiratory rate, circulatory signs (heart rate and blood pressure), autonomic effects (salivation, lacrimation, perspiration, piloerection, urinary incontinence and defecation) and central nervous system (ptosis, drowsiness, gait, tremors and convulsion changes were noted.^[@ref23]^

Subchronic oral toxicity study {#sec2-4}
------------------------------

Thirty male Wistar albino rats were divided into three groups of 10 rats per group. Group 1 served as the control and received standard feed and distilled water only. Groups 2 and 3 received standard feed, distilled water and CB at doses of 500 and 1000 mg kg^--1^ b.w. respectively.^[@ref24]^ Administration of the extract was done orally by means of a polythene cannula. Animals received their doses once a day for 9 weeks. They were observed daily for clinical signs of toxicity or pharmacological signs, throughout the period of study.

Samples collection {#sec2-5}
------------------

At the end of the treatment period, the animals were weighed and sacrificed using cervical dislocation method. Blood samples were obtained by cardiac puncture using 2 mL hypodermal syringe. The blood samples were introduced into clean dry anti-coagulant free bottles. The anti-coagulant free bottles containing the sample were centrifuged at 3000 rpm for 10 min to separate serum from packed cells, the serum obtained was collected into a clean dry sample bottle and used for the analysis of sodium, potassium, chloride and bicarbonate while the blood samples for hematological studies were collected into clean dry sample bottle containing ethylenediaminetetraacetic acid anticoagulant with the aim of preventing coagulation. White blood cell (WBC) count, lymphocytes, neutrophil, mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular hemoglobin (MCH) were estimated using a fully automated hematology analyzer. The auto counter utilized 20 µL of blood in 4.5 mL of a commercially prepared diluent.

Statistical analysis {#sec2-6}
--------------------

Values are expressed as means ± standard error of mean. The results were analyzed statistically by analysis of variance (ANOVA) followed by Turkey multiple comparison test. Significance was accepted at a P-value of 0.05.

Results {#sec1-3}
=======

The result of the acute toxicity showed no mortality or physical changes in skin and fur, eyes and mucus membrane (nasal), respiratory rate, circulatory signs (heart rate and blood pressure), autonomic effects (salivation, lacrimation, perspiration, piloerection, urinary incontinence and defecation) and central nervous system (ptosis, drowsiness, gait, tremors and convulsion) among rats administered 2000 mg kg^--1^ b.w. of CB. Since none of the mentioned toxic signs and symptoms or mortality was observed in the animals at the above mentioned dose, 500 and 1000 mg kg^--1^ b.w. of test drug were selected for the study. The results of the effect of oral administration of CB on serum electrolyte are showed in [Table 1](#table001){ref-type="table"}. Results from the study showed that administration of 500 and 1000 mg kg^--1^ b.w. of CB recorded a marked increase in the levels of sodium (Na^+^) and chlorum (Cl^--^) when compared with control. However, potassium (K^+^) and hydrogen carbonate (HCO~3~^--^) levels showed a marked reduction when compared with the control. In this present study, the results of the effects of CB on hematological parameters are shown in [Tables 2](#table002){ref-type="table"} and [3](#table003){ref-type="table"}. Results of the study showed that administration of 500 and 1000 mg kg^--1^ b.w. of CB recorded a significant (P≤0.05) decrease in the levels of hemoglobin (Hb), packed cell volume (PCV), red blood cells (RBCs), WBC, neutrophil and platelets when compared with control with the experimental rats in the group administered with 1000 mg kg^--1^ having the lowest hematological parameters level. However, the mean concentration of MCH and MCHC administered with 500 and 1000 mg kg^--1^ b.w. of CB did not show any significant (P≤0.05) difference as compared to the control. The result obtained from the study also showed that lymphocyte count as observed in the study in rats administered 1000 mg kg^--1^ b.w. of CB significantly (P≤0.05) increased as compared to the control.

Discussion and Conclusions {#sec1-4}
==========================

Toxicity studies of herbal drugs in animals are commonly used to assess potential health risk in humans, caused by intrinsic adverse effects of chemical compounds or plant extracts.^[@ref25]^ The deleterious effects of these extracts may be accompanied or preceded by clinical signs of toxicity such as salivation, loss of hair, changes in animal eye color, decreased respiratory rate and motor activity. The various biochemical parameters investigated in this study are useful indices that can be employed to assess the toxic potentials of plant extracts/botanicals in living systems.^[@ref26]^ Such toxicity testing is relevant to risk evaluation as changes in the hematological system have higher predictive value for human toxicity, when data are translated from animal studies.^[@ref27]^

The study investigated the effect of CB on serum electrolytes (Na^+^, Cl^--^, K^+^ and HCO~3~^--^) in male Wistar albino rats. CB is a polyherbal formula, which is commonly used in the treatment of muscle pain, joint pains, hypertension, stroke and anemia. Electrolytes are basically ions that conduct electricity in the body. The increase in the concentration of Na^+^ observed in rats administered 500 and 1000 mg kg^--1^ b.w. may have been as a result of sodium retention due to intrinsic renal disease or inadequate renal perfusion.^[@ref28]^ The reduction in the concentration of K^+^ in the group administered 500 mg kg^--1^ may be an indication of hypokalemia or severe depletion of potassium - showing kidney disease.^[@ref29]^ Potassium is the principal cation of intracellular fluids which is required for steady heartbeat. It has been reported that a decrease in potassium ion concentration in the cell causes muscles weakness which eventually leads to cardiac problems.^[@ref30]^ An increase in the concentration of Cl^--^ in the group administered 1000 mg kg^--1^ CB may be a sign of metabolic acidosis. On the other hand, a reduction in the concentration of HCO~3~^--^ in groups administered 500 and 1000 mg kg^--1^ b.w. CB is suggestive that the blood pH is acidic and could lead to the condition known, as acidemia.^[@ref28]^ Bicarbonate buffer system is the most important amongst blood buffers when the pH of the blood is considered.^[@ref31]^ Reduction in serum bicarbonates implies that the pH of the blood was lowered. This reduction may be attributed to two mechanisms: excessive respiratory excretion via hyperventilation, or increased renal excretion of bicarbonates.^[@ref32]^ Bicarbonate is an extracellular anion found in the blood which reflects acute changes in acid-base balance.

The observation of a reduction in the levels of Hb, PCV, RBC and platelets in male Wistar albino rats is suggestive that CB can directly or in directly or both destroy RBCs and lower the hemoglobin concentration. The indirect effects may be as a result of oxidative damage. It has been reported that when malonaldehyde is released in the tissues, it may destroy RBC and reduced erythrocytes survival.^[@ref33]^ Changes in hematological parameters such as Hb, PCV, RBC and platelets are routinely used to determine stress associated with environmental, nutritional and pathological factors.

Other hematological parameters namely: MCH, MCHC and MCV relates to individual red blood cells while Hb, RBC and PCV are associated with the total population of red blood cells.^[@ref34]^ The significant effect of CB on RBCs might be an indication that the balance between the rate of production and destruction of the blood corpuscles (erythropoiesis) was altered. That is, the significant (P≤0.05) decrease in the red blood cell and hemoglobin may have resulted from the suppression of circulating hormone, erythropoietin (a glycoprotein which stimulates the process of erythropoiesis).^[@ref35]^ Reduction in blood concentration of erythropoietin may result in a normochromic, normocytic anaemia.^[@ref36]^ Reduction in platelets count in experimental animals has been reported to indicate adverse effect on the oxygen- carrying capacity of the blood as well as thrombopoietin.^[@ref37]^ Results from this study show that the platelet count was significantly (P≤0.05) altered signifying that the oxygen carrying capacity of the blood was affected when CB was administered at a dose of 500 and 1000 mg kg^--1^ b.w. to the male Wistar rats. The MCV is an index of the size of the RBCs. When the MCV is below normal, the RBCs will be smaller than normal and are described as microcytic.^[@ref38]^ When the MCV is elevated, the RBCs will be larger than normal and are termed macrocytic. RBCs of normal size are termed normocytic.^[@ref39]^ These size categories are used to classify anaemias.^[@ref38]^ In this study, the RBC was below normal. When the RBC count is low, the body is not able to get as much oxygen to go throughout the bodies, which may result to anemia. CB also significantly increased bilirubin level in our previous study; these increased could lead to hemolytic anemia.^[@ref22]^ Conclusively, the abusive use of herbal remedies for various ailments should be put in check. Data from this study suggest that prolonged use of CB may have adverse effects on hematological indices and serum electrolytes. It is therefore; recommend that further studies be carried out at cellular and molecular levels in order to ascertain the toxicity potentials of CB.

Research highlights {#sec1-5}
===================

This study investigated the effect of class bitters® - a polyherbal formula on serum electrolytes and hematological parameters in male Wistar albino rats. Administration of 500 and 1000 mg kg^--1^ body weight (b.w.) of CB recorded a marked decrease in Hb, PCV, RBC and platelets concentrations. This study suggests that CB may have an adverse effect on erythropoiesis. Long-term administration may cause renal disease and anemia.

###### 

Effect of oral administration of class bitters^®^ on serum electrolytes.

  -----------------------------------------------------------------------------
  CB Conc.\     Na^+^\           K^+^\          Cl^-^\          HCO~3~^-^\
  (mg kg^-1^)   (mMol/L)         (mMol/L)       (mMol/L)        (mMol/L)
  ------------- ---------------- -------------- --------------- ---------------
  Control       153.00±5.66      10.07±0.80     113.6±8.78      16.50±2.04

  500           156.83±8.18^a^   8.25±0.98^a^   112.05±5.38     12.87±3.66^a^

  1000          155.83±8.33      9.53±1.35^a^   116.0±6.67^a^   13.90±3.70^a^
  -----------------------------------------------------------------------------

CB, class bitters®; Conc., concentration; Na^+^, sodium; K^+^, potassium; Cl^-^, chlorum; HCO~3~^-^, hydrogen carbonate. Values are mean ± standard deviation, (n=10); values with superscripts are significantly different at P≤0.05.

###### 

Effect of oral administration of class bitters^®^ on hematological parameters.

  CB Conc. (mg kg^-1^)   Hb (g/dL)       PCV (%)        RBC (10^6^/µL)   Platelets
  ---------------------- --------------- -------------- ---------------- -----------------
  Control                17.13±2.070     10.11±1.546    57.767±3.471     506±62.28
  500                    14.58±1.21^a^   6.96±1.75^a^   45.58±2.83^a^    323.17±78.34^a^
  1000                   10.00±1.52^a^   6.45±0.92^a^   43.85±8.36^a^    240.83±72.16^a^

CB, class bitters®; Conc., concentration; Hb, hemoglobin; PCV, packed cell volume; RBC, red blood cells count. Values are mean ± standard deviation, (n=10); values with superscripts are significantly different at P≤0.05.

###### 

Effect of oral administration of class bitters^®^ on hematological parameters.

  CB Conc. (mg kg^-1^)   WBC (10^3^/µL)   MCH (g/L)    MCHC (g/L)   Neutrophil (%)   Lymphocyte (%)
  ---------------------- ---------------- ------------ ------------ ---------------- ----------------
  Control                17.01±1.01       19.88±1.38   34.48±1.40   13.45±1.78       72.73±1.81
  500                    10.9±1.98^a^     19.4±1.51    33.7±1.51    11.88±1.94^a^    72.43±3.46
  1000                   8.02±1.75^a^     18.7±0.43    35.4±0.87    10.47±1.18^a^    80.23±7.12^a^

CB, class bitters®; Conc., concentration; WBC, whit blood cells count; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration. Values are mean ± standard deviation, (n=10); values with superscripts are significantly different at P≤0.05.
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